In relation with this last comment, in previous studies conducted in our laboratory, we have observed that tumor cells of BCPs (invasive ductal carcinoma, stage I/II) produce bone marrow-MSCs chemotactic substances, such as IL-6, SDF-1, and CCL-2, among others. The gene discussed is CCL2; the disease is invasive ductal breast carcinoma.